亿胜生物科技(01061)下跌5.28%，报2.33元/股

金融界06-18

6月18日，亿胜生物科技(01061)盘中下跌5.28%，截至15:39，报2.33元/股，成交101.22万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2023年年报，亿胜生物科技营业总收入15.47亿元、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2444708091?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-18 15:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2444708091","market":"hk","top_or_hot":-1,"title":"亿胜生物科技(01061)下跌5.28%，报2.33元/股","media":"金融界","content":"<div>\n<p>6月18日，亿胜生物科技(01061)盘中下跌5.28%，截至15:39，报2.33元/股，成交101.22万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2023年年报，亿胜生物科技营业总收入15.47亿元、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181541519f49773f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亿胜生物科技(01061)下跌5.28%，报2.33元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亿胜生物科技(01061)下跌5.28%，报2.33元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-18 15:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181541519f49773f&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月18日，亿胜生物科技(01061)盘中下跌5.28%，截至15:39，报2.33元/股，成交101.22万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2023年年报，亿胜生物科技营业总收入15.47亿元、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181541519f49773f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181541519f49773f&s=b","article_id":"2444708091","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406181541519f49773f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2444708091","pubTimestamp":1718696374,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"6月18日，亿胜生物科技(01061)盘中下跌5.28%，截至15:39，报2.33元/股，成交101.22万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2023年年报，亿胜生物科技营业总收入15.47亿元、净利润2.49亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01061":"亿胜生物科技","BK1161":"生物科技"},"translate_title":"Essex Biotechnology (01061) fell 5.28% to 2.33 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"6月18日，亿胜生物科技(01061)盘中下跌5.28%，截至15:39，报2.33元/股，成交101.22万元。亿胜生物科技有限公司主要业务是生产和销售治疗体表创伤和眼部损伤的生物药品，同时也代理分销和推广第三方医药产品。该公司已成功开发出一系列基因工程生物药品，其中三项产品被归类为国家级I类新药，主要品牌包括贝复济、贝复舒和贝复新。截至2023年年报，亿胜生物科技营业总收入15.47亿元、净利润2.49亿元。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2444708091"}